Last update 20 Mar 2025

hNPC-01

Overview

Basic Info

Drug Type
Induced pluripotent stem cells (iPSC), Neural stem cell therapy
Synonyms
人前脑神经前体细胞（浙江霍德）
+ [1]
Target-
Action-
Mechanism
Cell replacements
Therapeutic Areas
Nervous System DiseasesCardiovascular DiseasesOther Diseases
Active Indication
Ischemic strokestroke; sequelaeBrain Injuries, Traumatic+ [1]
Inactive Indication-
Originator Organization
Hopstem Biotechnology Inc.Hopstem Biotechnology Inc.
Active Organization
Hopstem Biotechnology Inc.Hopstem Biotechnology Inc.
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with hNPC-01
CTR20233368
/ RecruitingPhase 1
评价人诱导多能干细胞来源的前脑神经前体细胞注射液改善缺血性脑卒中偏瘫后遗症的剂量递增、单中心、开放标签的安全性和耐受性的临床研究
[Translation] A dose-escalation, single-center, open-label clinical study to evaluate the safety and tolerability of human induced pluripotent stem cell-derived forebrain neural progenitor cell injection to improve the sequelae of hemiplegia after ischemic stroke
NCT06299033
/ RecruitingPhase 1
A Phase 1 Dose-escalation, Single-Center, Open-labeled Study to Evaluate the Safety and Tolerability of Human Induced Pluripotent Stem Cell-derived Human Forebrain Neural Progenitor Cell Injection (hNPC01) in Chronic Ischemic Stroke
100 Clinical Results associated with hNPC-01
Login to view more data
100 Translational Medicine associated with hNPC-01
Login to view more data
100 Patents (Medical) associated with hNPC-01
Login to view more data
100 Deals associated with hNPC-01
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Ischemic strokePhase 1
China
Hopstem Biotechnology Inc.Hopstem Biotechnology Inc.
09 Nov 2023
stroke; sequelaePhase 1
China
Hopstem Biotechnology Inc.Hopstem Biotechnology Inc.
09 Nov 2023
Brain Injuries, TraumaticPreclinical
China
Hopstem Biotechnology Inc.Hopstem Biotechnology Inc.
25 Jul 2022
Cerebral PalsyPreclinical
China
Hopstem Biotechnology Inc.Hopstem Biotechnology Inc.
25 Jul 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free